Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Trop Anim Health Prod ; 52(5): 2753-2759, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32458353

ABSTRACT

Natural pastures are the primary sources of feed for ruminant in southwest Nigeria, but they are of poor quality. Oversowing of legumes could augment the nutrients supplied by the poor forages but this is rarely explored. Here, we oversowed two legumes (Stylosanthes guianensis cv. Cook and Stylosanthes hamata cv. Verano) into natural pasture using different tillage methods (zero-tillage and minimal tillage) and sowing methods (broadcast or drill), and examined their macro and trace minerals. We found that the two legumes produced similar (p > 0.05) calcium, phosphorus, and potassium in all treatments, while magnesium and sodium contents significantly differ (p < 0.05). The two legumes were generally rich in macrominerals far beyond the requirements of ruminants and low in trace mineral concentrations irrespective of the treatments imposed. Thus, we recommend oversowing of these two legumes into natural pasture for an adequate supply of major minerals and enhanced livestock productivity in the region of study and beyond. Other sources of trace minerals should be assessed if the natural pasture could not supply them.


Subject(s)
Agriculture/methods , Animal Feed/analysis , Fabaceae/chemistry , Trace Elements/analysis , Animals , Calcium, Dietary/analysis , Magnesium/analysis , Minerals , Nigeria , Nutrients , Phosphorus/analysis
2.
Niger Postgrad Med J ; 15(4): 215-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19169336

ABSTRACT

OBJECTIVES: Aspirin and selenium have been shown in vitro and in vivo to inhibit HIV production through inhibition of the transcription factor, the nuclear factor kappa binding (NF-eB). The aim of this study was to examine the efficacy or otherwise of these drugs in people living with HIV and AIDS (PLWAS) in resource limited countries. PATIENTS AND METHODS: Consenting HAART-naive PLWAS with mean CD4 count of 256.8 +/- 67.6 cells/ul were recruited into the study. Pretherapy blood count, serum biochemistry, chest x-ray, urinary glucose and protein and microscopy and culture of both urine and stool were checked in all cases. Each patient was treated for six months and CD4 counts were repeated at the end of the study. Thirty two patients (23 (72%) females and nine (28%) males), aged 22-52 (median = 36) years were recruited. Twenty-three (72%) were randomised into selenium and aspirin (SAM) and nine (28%) into selenium (SM); multivitamin was added to each arm. RESULTS: Eighteen (56.2%) patients completed the study. Sixteen (88.9%) patients are already on HAART since the termination of the study; one absconded and one died of disease progression. Fourteen (43.8%) of the initial 32 patients dropped out (11 (78.6%) were lost to follow-up, two (14.3%) died and one (7.1%) opted for HAART before completing the study). The post-treatment CD4 count was 293.0 +/-102.2 cells/ml, compared to the pre-therapy mean of 256.8 +/- 67.6 cells/ul, an average rise of 36.2 cells/ul, the difference was not statistically significant (p = 0.059). The post-therapy mean weight was significantly higher than the pretherapy weight, 61.6+/-15.2 kg versus 60.0+/-14.3 kg (p = 0.015). CONCLUSION: The SAM/SM combination regimen improved the quality of life of PLWAS, however, a greater number of patients and a longer period of follow up, are necessary to arrive at a more meaningful conclusion.


Subject(s)
Acquired Immunodeficiency Syndrome/drug therapy , Anti-HIV Agents/pharmacology , Aspirin/pharmacology , HIV Infections/drug therapy , HIV-1/drug effects , Selenium/pharmacology , Acquired Immunodeficiency Syndrome/virology , Adult , Anti-HIV Agents/therapeutic use , Aspirin/therapeutic use , Black People , Body Weight , CD4 Lymphocyte Count , Drug Therapy, Combination , Female , HIV Infections/virology , HIV-1/genetics , Humans , Male , Middle Aged , Nigeria , Selenium/therapeutic use , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...